Tag: BD
Aspirex achieves 78% two-year primary patency rate in P-MAX postmarket observational...
At the Leipzig Interventional Course (LINC) 2024 (28–31 May, Leipzig, Germany), Michael Lichtenberg (Arnsberg Vascular Clinic, Arnsberg, Germany) shared for the first time a...
Nitinol stents placed in iliac veins “not associated with prolonged back...
In a retrospective review of over 600 patients who underwent iliac vein stent placement, the development of back pain was found to be unrelated...
AVeVA study confirms benefit of covered stent placement in graft-vein anastomotic...
A prospective, multicenter study involving the Covera vascular covered stent (BD) has confirmed the benefits of immediate, post-percutaneous transluminal angioplasty (PTA) placement of the...
Venovo venous stent returns to US market after 2021 recall
BD recently announced that its Venovo venous stent is back on the U.S. market following a recall last year.
In 2019, the company reported that the...
Database analysis findings ‘matched precisely’ with reported reasons for venous stent...
A recent analysis recalled Venovo and Vici venous stents—initiated last year—characterized “significant differences” between reported device and patient issues, and subsequent interventions for the...
Boston Scientific and BD initiate venous stent recalls
Boston Scientific and BD have both initiated recalls of venous stents. According to a Food and Drug Administration (FDA) medical device recall notice posted...
Enrollment starts in postmarket studies of WavelinQ endoAVF system
Enrollment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV, of the WavelinQ (BD) endovascular arteriovenous fistula (endoAVF)...
BD acquires Straub Medical
Straub Medical, which manufactures, develops and sells medical devices for the treatment of arterial and venous diseases, has been acquired by Becton, Dickinson and...